Compound class:
Synthetic organic
Comment: Compound G1 is an orally bioavailable epoxide hydrolase 2 (EPHX2; also known as soluble epoxide hydrolase, sEH) inhibitor that was developed for anti-inflammatory activity [1]. It is proposed as a potential drug candidate for inflammation-driven diseases such as arthritis, acute pancreatitis, and sepsis.
Ligand Activity Visualisation ChartsThese are box plot that provide a unique visualisation, summarising all the activity data for a ligand taken from ChEMBL and GtoPdb across multiple targets and species. Click on a plot to see the median, interquartile range, low and high data points. A value of zero indicates that no data are available. A separate chart is created for each target, and where possible the algorithm tries to merge ChEMBL and GtoPdb targets by matching them on name and UniProt accession, for each available species. However, please note that inconsistency in naming of targets may lead to data for the same target being reported across multiple charts. ✖ |
|
References |
1. Chen Y, Chen L, Xu H, Cao R, Morisseau C, Zhang M, Shi Y, Hammock BD, Wang J, Zhuang J et al.. (2023)
Structure-Directed Discovery of Potent Soluble Epoxide Hydrolase Inhibitors for the Treatment of Inflammatory Diseases. J Med Chem, 66 (4): 2979-3009. [PMID:36689364] |